Kiniksa Pharmaceuticals International, plc (KNSA)

SEC filing

Kiniksa Pharmaceuticals International, plc

KNSA · CIK 1730430

4 · Feb 11, 2026 · Ragosa Mark sold 17.84K shares at $43.28/share ($772.3K); exercised options for 10.85K shares

Ragosa Mark sold 17.84K shares at $43.28/share ($772.3K); exercised options for 10.85K shares

xslF345X05/form4-02112026_090228.xml

xslF345X05/form4-02112026_090228.xmlSEC.gov

Graphics and non-inline formats (not embedded below).